Heparin-induced thrombocytopenia in myeloproliferative disorders: A rare or under-diagnosed complication?

Galia Spectre*, Yossi Kalish, Liliana Schliamser, David Varon

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

Patients with myeloproliferative disorders (MPD) are prone to develop thrombotic complications and thus frequently receive heparin. Surprisingly heparin-induced thrombocytopenia (HIT) has been rarely reported in MPD and is potentially under-diagnosed due to the relatively high platelet count. We report three patients with MPD who developed HIT; all presented with a relative fall of platelet counts (although without an absolute thrombocytopenia), thrombosis or skin necrosis and a positive test for HIT antibodies (particle gel immunoassay). Risk factors for developing HIT in our patients were exposure to unfractionated heparin, a recent surgical procedure and female gender. We review the literature on HIT in MPD and discuss the diagnosis of HIT in the absence of an absolute thrombocytopenia.

Original languageEnglish
Pages (from-to)420-423
Number of pages4
JournalAmerican Journal of Hematology
Volume83
Issue number5
DOIs
StatePublished - May 2008
Externally publishedYes

Fingerprint

Dive into the research topics of 'Heparin-induced thrombocytopenia in myeloproliferative disorders: A rare or under-diagnosed complication?'. Together they form a unique fingerprint.

Cite this